Scott M. Rocklage has been in the health care management business for over three decades. Rocklage has worked in server companies before becoming a venture and managing partner at 5AM Ventures in 2003. The company 5AM is venture capital company that is dedicated to doing returns with their investors that relate to life science companies. The investors that work at the company have certain skills that apply to scientific, legal, medical, finance expertise and operational. 5AM depends on a hands-on approach and is involved in all of the work that they do as a business. Scott Rocklage on LinkedIn.
Previously Rocklage has worked as the Chairman and CEO of Cubist Pharmaceuticals. Rocklage also had various occupations at Salutar and Catalytic that include being the President as well as the CEO of Nycomed Salutar. Scott was also the Executive Chairman at Semprus, Ilypsa, and Miikana. Rocklage is also an inventor that has contributed to over 30 U.S. patents and more than 100 peers reviewed publications. Before Rockledge begin his career in healthcare, he obtained his Bachelor of Science in Chemistry from the University of California. He also receives a Ph.D. in Chemistry from the Massachusetts Institute of Technology.
Scott Rocklage is also the Board Chairman of the companies Relypsa, Achaogen, and Semprus. As of today Scott continues to work in health care management and is constantly looking for new and inventive ways to make health care management better. Scott has placed all of his heart and hard work to make sure that health management will be better for our present and our future.